Literature DB >> 9780989

Ductography for nipple discharge: no replacement for ductal excision.

L G Dawes1, C Bowen, L A Venta, M Morrow.   

Abstract

BACKGROUND: Current management of nipple discharge depends on clinical history to distinguish pathologic from physiologic discharge. We investigated whether ductography supplied additional information in the decision for surgery and/or the localization of pathologic lesion.
METHODS: A retrospective review of patients with a presenting complaint of nipple discharge seen at the Lynn Sage Breast Center was conducted from January 1995 to June 1996. Medical records, pathology, and ductograms were reviewed.
RESULTS: Of 91 patients with nipple discharge, 49 met the criteria for physiologic discharge and 42 had pathologic discharge. Eleven with physiologic discharge had ductograms; none were abnormal. Four of 20 preoperative ductograms were normal but showed intraductal papillomas at the time of surgery; 6 of 20 (30%) had multiple lesions. Four lesions on ductograms did not demonstrate corresponding lesions in the surgical specimen. It is uncertain whether this is due to a missed lesion or a false-positive ductogram.
CONCLUSIONS: Modern ductography does not reliably exclude intraductal pathology and is not a substitute for surgery in patients with pathologic discharge. Its utility is in identifying multiple lesions or those with lesions in the periphery of the breast.

Entities:  

Mesh:

Year:  1998        PMID: 9780989     DOI: 10.1067/msy.1998.91362

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Management of bloody nipple discharge.

Authors:  Hernan I Vargas; Lina Romero; Rowan T Chlebowski
Journal:  Curr Treat Options Oncol       Date:  2002-04

Review 2.  Exploring breast with therapeutic ductoscopy.

Authors:  Fatih Levent Balci; Sheldon Marc Feldman
Journal:  Gland Surg       Date:  2014-05

Review 3.  Comparison of ductoscopy, galactography, and imaging modalities for the evaluation of intraductal lesions: a critical review.

Authors:  Ozgur Sarica; Enis Ozturk; Huseyin C Demirkurek; Fatih Uluc
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

4.  Role of galactography in the early diagnosis of breast cancer.

Authors:  Juan D Berná-Serna; Carolina Torres-Ales; Juan D Berná-Mestre; Luis Polo
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

5.  A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge.

Authors:  Robyn M Moncrief; Ritu Nayar; Leslie K Diaz; Valerie L Staradub; Monica Morrow; Seema A Khan
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

6.  Galactography in patients with nipple discharge.

Authors:  J P Lamont; R P Dultz; J A Kuhn; M D Grant; R C Jones
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-07

7.  Management strategies for patients with nipple discharge.

Authors:  Husnu A Goksel; Mahmut C Yagmurdur; Beyhan Demirhan; Iclal Isiklar; Hamdi Karakayali; Nevzat Bilgin; Mehmet Haberal
Journal:  Langenbecks Arch Surg       Date:  2004-09-14       Impact factor: 3.445

8.  Use of fiberoductoscopy for the management of pathological nipple discharge: ten years follow up of a single center in China.

Authors:  Chao Zhang; Jie Li; Hongchuan Jiang; Mengxin Li
Journal:  Gland Surg       Date:  2020-12

9.  The role of major duct excision and microdochectomy in the detection of breast carcinoma.

Authors:  Mary F Dillon; Shah R Mohd Nazri; Shaaira Nasir; Enda W McDermott; Denis Evoy; Thomas B Crotty; Niall O'Higgins; Arnold D K Hill
Journal:  BMC Cancer       Date:  2006-06-23       Impact factor: 4.430

10.  Breast MRI in patients with unilateral bloody and serous-bloody nipple discharge: a comparison with galactography.

Authors:  Lucia Manganaro; Ilaria D'Ambrosio; Silvia Gigli; Francesca Di Pastena; Guglielmo Giraldi; Stefano Tardioli; Marialuisa Framarino; Lucio Maria Porfiri; Laura Ballesio
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.